Impax Asset Management Group
ALNY icon

Impax Asset Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Impax Asset Management Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,587
Closed -$495K – 309
2023
Q4 		$495K Sell
2,587
-316
-11% -$53.8K ﹤0.01% 340
2023
Q3 		$514K Sell
2,903
-165
-5% -$31.5K ﹤0.01% 330
2023
Q2 		$583K Buy
3,068
+48
+2% +$9.52K ﹤0.01% 327
2023
Q1 		$605K Buy
3,020
+312
+12% +$65.6K ﹤0.01% 308
2022
Q4 		$644K Sell
2,708
-954
-26% -$203K ﹤0.01% 298
2022
Q3 		$733K Buy
3,662
+350
+11% +$66.8K ﹤0.01% 290
2022
Q2 		$483K Sell
3,312
-786
-19% -$112K ﹤0.01% 325
2022
Q1 		$669K Buy
4,098
+307
+8% +$46.8K ﹤0.01% 322
2021
Q4 		$642K Sell
3,791
-12,521
-77% -$2.33M ﹤0.01% 332
2021
Q3 		$3.08M Buy
16,312
+66
+0.4% +$12.4K 0.01% 220
2021
Q2 		$2.75M Buy
16,246
+1
+0% +$146 0.01% 226
2021
Q1 		$2.29M Buy
16,245
+110
+0.7% +$16.6K 0.01% 234
2020
Q4 		$2.1M Sell
16,135
-35,031
-68% -$4.68M 0.01% 201
2020
Q3 		$7.45M Buy
51,166
+21,074
+70% +$2.99M 0.07% 129
2020
Q2 		$4.46M Buy
30,092
+8,754
+41% +$1.18M 0.05% 160
2020
Q1 		$2.32M Buy
21,338
+18,879
+768% +$2.18M 0.03% 187
2019
Q4 		$283K Buy
+2,459
New +$245K ﹤0.01% 263

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Impax Asset Management Group's ALNY Position: Q1 2024 in Review

Impax Asset Management Group sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2024, closing a stake of 2,587 shares — an estimated $495K sold.

Impax Asset Management Group first reported a position in ALNY in Q4 2019 and held it in 17 quarters. The position peaked at $7.45M in Q3 2020. 499 funds tracked by Wall St. Rank hold ALNY as of Q1 2024.

  • Impax Asset Management Group reported no remaining Alnylam Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 2,587 Alnylam Pharmaceuticals shares in Q1 2024, an estimated $495K.
  • Impax Asset Management Group first reported a position in Alnylam Pharmaceuticals in Q4 2019 and held it in 17 quarters.
  • Impax Asset Management Group's Alnylam Pharmaceuticals position peaked at $7.45M in Q3 2020.
  • 499 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2024.

Based on Impax Asset Management Group's 13F filing for Q1 2024, filed 30 Apr 2024.